Endoscopy in IBD: When and How?
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endoscopy is an essential tool supporting inflammatory bowel disease diagnosis, and ileocolonoscopy is essential to the diagnostic process because it allows for histological sampling. A decent description of endoscopic lesions may lead to a correct final diagnosis up to 89% of the time. Moreover, endoscopy is key to evaluating endoscopic severity, which in both Crohn’s disease and ulcerative colitis is associated with worse disease outcomes (e.g., more frequent advanced therapy requirements or more frequent hospitalizations and surgeries). Endoscopic severity should be reported according to validated endoscopic scores, such as the Mayo endoscopic subscore (MES) or the ulcerative colitis endoscopic index of severity (UCEIS) for ulcerative colitis, the Rutgeerts score for postoperative Crohn’s recurrence, and the Crohn’s disease endoscopic index of severity (CDEIS) or the simplified endoscopic score for Crohn’s disease (SES-CD) for luminal Crohn’s disease activity. The measuring of endoscopic activity has become a regulatory agency requirement to increase the objective evaluation of disease activity and drug response. In recent years, the central reviewing of endoscopic videos has become a standard for clinical trials. However, the adjudication paradigm and the type of endoscopic reading may substantially affect trial outcomes, and the reproducibility of all endoscopic scores is not perfect as they require the interpretation of intrinsically subjective images. This paper reviews and discusses the available evidence on inflammatory bowel disease endoscopy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 From Riviere et al.’s paper [20]. (A). Graphical representations of the different types of ileocolonic anastomoses. (B). Graphical overlay of color legend according to an endoscopic picture in order to differentiate different parts of the anastomotic anatomy. For different anastomotic shapes, the endoscopist should refer to different terminology. Areas of interest are the neoterminal ileum, the ileal inlet (the area approximately 1 cm from where there is the passage between the anastomotic body and the afferent ileal limb), the ileal anastomotic body, the ileal blind loop, the anastomotic line (where the ileal and colonic walls are in direct contact), and the colonic blind loop. Not all anastomotic shapes have all these elements, but considering the type of anastomosis, the report should refer elemental lesions to the correct areas.](https://figures.cochat.ai/paper-figures/efd0d8958c5e4759a5bdfad087ed4de1/endoscopy-in-ibd-when-and-how-figure-2.jpg)

![Figure 4 (A–D) The theoretical exercise an endoscopist should carry out to score the percentage of an ileocolonic segment affected by ulcers (the same applies to the affected surface, too) [32]. (A) Endoscopic exploration of an ileocolonic segment reveals ulcers of different widths at different points. (B) The endoscopist should imagine the segment as opened wide in a two-dimensional plane, such as after dissecting it across its longitudinal axis. (C) The observer should imagine the surface occupied by ulcers as a sum of areas compared with the total segment surface, leading to a percentage. (D) The observer can now draw the corresponding sign on a visual analog scale and measure it in centimeters (for CDEIS calculation) or compare it with the corresponding Likert scale (for SES-CD calculation).](https://figures.cochat.ai/paper-figures/020cbc2fc8cd4951b9431073ec25dff5/endoscopy-in-ibd-when-and-how-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the validation study, the algorithm exhibited a significant but moderate correlation with MES and UCEIS (r 0.61 and 0.56, respectively) and histologic scores ( r 0.65) in UC.”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“Moreover, recently developed Red Density (RD), a digital endoscopic tool, can also calculate the grade of inflammation in UC using an automated RD score based on assessing redness on a pixel level.27”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Satsangi, J., Silverberg, M. S., Vermeire, S., & Colombel, J.-F. (2006) · Gut · doi:10.1136/gut.2005.082909 · Cited by 3,176
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026 · cited 2×
“• The Mayo endoscopic subscore (MES) [25] and the ulcerative colitis endoscopic index of severity (UCEIS) [26] for ulcerative colitis; This point is di ffi cult to dissect via clinical trials.”
BackgroundCortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Gomollón, F., Dignass, A., Annese, V., Tilg, H., Van Assche, G., Lindsay, J. O., Peyrin-Biroulet, L., Cullen, G. J., Daperno, M., Kucharzik, T., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw168 · Cited by 2,057 · cited 2×
“…and laboratory and pathological findings) is ileo-colonoscopy, which enables a reliable diagnosis in slightly less than 9 out of 10 of cases [1], allows tissue sampling to support pathological reports, and is considered the mainstay of IBD diagnosis per the current ECCO guidelines [2,3].”
BackgroundMethodSelf-citationMaaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823 · cited 2×
“…and laboratory and pathological findings) is ileo-colonoscopy, which enables a reliable diagnosis in slightly less than 9 out of 10 of cases [1], allows tissue sampling to support pathological reports, and is considered the mainstay of IBD diagnosis per the current ECCO guidelines [2,3].”
BackgroundMethodPredictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820 · cited 5×
“The MES 0 degree includes both completely normal-appearing mucosa and areas of healing (with scarring (see Figure 3A) or with post-inflammatory polyps, regardless of erosions on their tops), but no erythema, friability, erosions, or ulcers are admitted, and the vascular pattern should be clearly…”
BackgroundMethodInfluentialDaperno, M., D'Haens, G., Van Assche, G., Baert, F., Bulois, P., Maunoury, V., Sostegni, R., Rocca, R., Pera, A., Gevers, A., et al. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01878-4 · Cited by 1,774
Self-citationColombel, J. F., Rutgeerts, P., Reinisch, W., Esser, D., Wang, Y., Lang, Y., Marano, C. W., Strauss, R., Oddens, B. J., Feagan, B. G., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.054 · Cited by 919
Mary, J. Y., & Modigliani, R. (1989) · Gut · doi:10.1136/gut.30.7.983 · Cited by 884
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Baert, F., Moortgat, L., Van Assche, G., Caenepeel, P., Vergauwe, P., De Vos, M., Stokkers, P., Hommes, D., Rutgeerts, P., Vermeire, S., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.056 · Cited by 830 · cited 2×
“Using as many reproduced and reproducible scores (the minimal standards are the MES and/or UCEIS for UC and the SES-CD and the Rutgeerts score for CD) as possible and documenting the most representative endoscopic features using videos/still images.”
BackgroundMethod
Research works printed but not linked: 1
- Abreu, L.E. (2014). Endoscopy in Inflammatory Bowel Disease, Elsevier Doyma.
Cited by
Iacucci, M., Santacroce, G., Zammarchi, I., Maeda, Y., Del Amor, R., Meseguer, P., Kolawole, B. B., Chaudhari, U., Di Sabatino, A., Danese, S., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00053-0 · Cited by 73
Silverman, A. L., Shung, D. L., Stidham, R. W., Kochhar, G. S., & Iacucci, M. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.048 · Cited by 33
Current Approaches for Monitoring of Patients with Inflammatory Bowel Diseases: A Narrative Review
Vitello, A., Maida, M. F., Shahini, E., Macaluso, F. S., Orlando, A., Grova, M., Ramai, D., Serviddio, G., & Facciorusso, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041008 · Cited by 27
“Scoring systems have been developed to stratify endoscopic severity, with Simple Endoscopic Score for Crohn’s Disease (SES-CD) and Mayo Endoscopic Sub-score (eMAYO) being the most commonly used in clinical practice [12,38,39].”
MethodNrf2 as a Molecular Guardian of Redox Balance and Barrier Integrity in IBD
Stojanović, B., Bevc, I. M., Stojanovic, M. D., Stojanović, B., Jovanović, M., Lazarevic, S. R., Milošević, B., Radosavljević, I., Tasić-Uroš, D., Marković, N., et al. (2025) · Antioxidants · doi:10.3390/antiox14121407 · Cited by 25
Endoscopic healing in IBD: Still the target to achieve?
Buda, A., Pessarelli, T., Aldinio, G., Bona, M. D., Iacucci, M., & Tontini, G. E. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.02.009 · Cited by 8
Advances in biosensors for diagnosis and monitoring of inflammatory bowel disease: A review
Fu, W., Xue, R., Shivdasani, M. N., Wu, Y., Chen, D., Guo, T., Lovell, N. H., Goldys, E. M., Xiang, T., Huang, Y., et al. (2025) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70064 · Cited by 10
“Current methods for identifying, diagnosing, and monitoring IBD include different endoscopy techniques, 10,15 – 17 imaging techniques 18 – 20 and other approaches 21 (Figure 1).”
Wu, W., Jin, Y., Zhu, D., Wang, J., Cheng, Y., & Zhang, L. (2024) · Insights into Imaging · doi:10.1186/s13244-024-01628-5 · Cited by 4
“Furthermore, endoscopy may be warranted in the event of a significant alteration in the treatment regimen or to rule out active inflammation that may impact treat-ment choices [7].”
BackgroundLu, J., Xu, H., Zheng, J., Cheng, T., Han, X., Wang, Y., Meng, X., Li, X., Jiang, J., Dong, X., et al. (2025) · Korean Journal of Radiology · doi:10.3348/kjr.2024.0857 · Cited by 3
Role of Endoscopy in Inflammatory Bowel Disease: What Every Gastroenterologist Should Know
Kochhar, G. S., Dziegielewski, C., Schairer, J., & Cross, R. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003507 · Cited by 3
Advancements in the use of AI in the diagnosis and management of inflammatory bowel disease
Braverman-Jaiven, D., & Manfredi, L. (2024) · Frontiers in Robotics and AI · doi:10.3389/frobt.2024.1453194 · Cited by 3
“…are a few scoring systems to aid in the diagnosis and classification of IBD the Mayo Endoscopic Subscore (MES), the ulcerative colitis endoscopic index of severity (UCEIS), the Crohn’s disease index of severity (CDEIS), and the simple endoscopic score for Crohn’s disease (SES-CD) (Daperno, 2023).”
BackgroundMethodInfluentialIndicators of the quality of care for inflammatory bowel diseases in the tertiary center
Kaibullayeva, J. A., Орумбасарович, П. М., Z.Kh., A., Tanabayeva, A., Ualiyeva, A. E., Yesbatyrova, L. M., Tatibekov, B. L., Kumar, A., & Nauryzbayeva, A. (2024) · Medicine and ecology · doi:10.59598/me-2305-6045-2024-110-1-61-69 · Cited by 2
Endoscopic assessment and scoring in pediatric inflammatory bowel disease: A consensus from SIGENP
Bramuzzo, M., Renzo, S., Labriola, F., Arrigo, S., Lega, S., Miele, E., Norsa, L., Oliva, S., Romano, C., & Angelis, P. D. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.05.020 · Cited by 2
Mendolaro, M., & Daperno, M. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70015
Self-citationZittan, E., Levy, M. N., Vered, S., Steinhart, A. H., Milgrom, R., Silverberg, M. S., & Zelber‐Sagi, S. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf142
“21,32 The results of this study demonstrate that the TIGER score has clinical value as a predictive tool for disease progression and therapeutic outcomes.”
Lu, J., Xu, H., Zhang, J., Cheng, T., Zheng, J., Han, X., Wang, Y., Meng, X., Li, X., Jiang, J., et al. (2025) · European Radiology · doi:10.1007/s00330-025-12079-x
“A previous study con fi rmed that the most severe endoscopic lesion was associated with the worst disease outcome [19].”
Xu, W., Zheng, L., Zhang, K., & He, B. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1634056
“Endoscopic and histological evaluation is essential for the confirmation of CD, while the application is limited by the inability to observe the bowel wall architecture, the subjective interpretation, and the low tolerance of patients (16).”
Beyond conventional endoscopy: Image-enhanced techniques in quiescent ulcerative colitis assessment
Tomašić, V., Čačić, P., Baršić, N., & Bišćanin, A. (2026) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v18.i1.113749
Personalized gastroenterology: Inflammatory bowel disease
Mahmood, S., Saeed, A., Nawaz, S., & Saleem, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00022-4
Wang, S., Chen, S., Ma, X., Wu, T., Zuo, P., Tang, X., Zhang, Y., Zhang, X., & Hou, E. (2026) · Medicine · doi:10.1097/md.0000000000048126
Purplish Terminal Ileum: Adult IgA Vasculitis Mimicking Crohn's Disease
Diaz-Moreno, J., Naeem, R., Kruer, J., & Dwivedi, S. (2026) · ACG Case Reports Journal · doi:10.14309/crj.0000000000002201
“14 Awareness of these vascular-appearing mucosal changes is critical when evaluating terminal ileitis of unclear etiology, particularly in the setting of acute presentation and concurrent or evolving cutaneous fi ndings.”
Metadata
- Authors
- Daperno, M.
- Affiliations
- A. O. Ordine Mauriziano di Torino (IT)
- Corresponding author
- Daperno, Marco
- ORCID
- Daperno, Marco
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2023-11-10
- Volume
- 13
- Issue
- 22
- Pages
- 3423
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC10670128
- OpenAlex
- W4388568432
- Cited by
- 20
- References
- 38
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 6
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- inflammatory bowel disease, ileocolonoscopy, endoscopic score, Mayo endoscopic subscore, UCEIS, Rutgeerts score, SES-CD, Crohn's disease, ulcerative colitis, endoscopic activity, central adjudication, disease activity assessment, histological sampling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.